ATE204018T1 - Zellwachstumsinhibitoren - Google Patents

Zellwachstumsinhibitoren

Info

Publication number
ATE204018T1
ATE204018T1 AT91918746T AT91918746T ATE204018T1 AT E204018 T1 ATE204018 T1 AT E204018T1 AT 91918746 T AT91918746 T AT 91918746T AT 91918746 T AT91918746 T AT 91918746T AT E204018 T1 ATE204018 T1 AT E204018T1
Authority
AT
Austria
Prior art keywords
pct
gbp
cell growth
sec
show
Prior art date
Application number
AT91918746T
Other languages
English (en)
Inventor
Livio Mallucci
Valerie Wells
Original Assignee
Livio Mallucci
Valerie Wells
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10684796&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE204018(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Livio Mallucci, Valerie Wells filed Critical Livio Mallucci
Application granted granted Critical
Publication of ATE204018T1 publication Critical patent/ATE204018T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91918746T 1990-11-02 1991-10-30 Zellwachstumsinhibitoren ATE204018T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909023907A GB9023907D0 (en) 1990-11-02 1990-11-02 Cell growth inhibitors
PCT/GB1991/001898 WO1992007938A1 (en) 1990-11-02 1991-10-30 Cell growth inhibitors

Publications (1)

Publication Number Publication Date
ATE204018T1 true ATE204018T1 (de) 2001-08-15

Family

ID=10684796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918746T ATE204018T1 (de) 1990-11-02 1991-10-30 Zellwachstumsinhibitoren

Country Status (11)

Country Link
US (1) US6127169A (de)
EP (1) EP0555286B1 (de)
JP (1) JP3497504B2 (de)
AT (1) ATE204018T1 (de)
AU (1) AU650066B2 (de)
CA (1) CA2095335C (de)
DE (1) DE69132682T2 (de)
GB (2) GB9023907D0 (de)
IE (1) IE913816A1 (de)
IL (1) IL99940A0 (de)
WO (1) WO1992007938A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134443A1 (en) * 1992-04-27 1993-11-11 Terry C. Johnson Inhibitory factor
US5916871A (en) * 1992-04-27 1999-06-29 Kansas State University Research Foundation Inhibitory factor
ZA946595B (en) * 1993-09-03 1996-02-28 Res Dev Foundation Mutants of the retinoblastoma and P53 genes and uses thereof
WO1999012041A1 (en) * 1997-09-05 1999-03-11 The Board Of Regents Of The University Of Oklahoma Composition and methods using galectin-1
US5948628A (en) 1997-09-05 1999-09-07 The Board Of Regents Of The University Of Oklahoma Methods of screening for compounds which mimic galectin-1
JP2002322082A (ja) * 2001-04-26 2002-11-08 Purotejiin:Kk 腎炎の予防・治療剤
GB2450146A (en) * 2007-06-14 2008-12-17 Livio Mallucci ßGBP, compositions comprising ßGBP, and related methods and uses thereof
US7994113B2 (en) 2007-06-14 2011-08-09 Livio Mallucci βGBP, compositions comprising βGBP, and related methods and uses thereof
EP2167597B1 (de) * 2007-06-15 2013-05-01 Basf Se Voc-arme wässrige hybridbindemittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63164895A (ja) * 1986-09-13 1988-07-08 Sanwa Kagaku Kenkyusho Co Ltd 培養細胞由来のレクチン様蛋白質及びその製法並びに該物質を主成分とする抗腫瘍剤
ATE165980T1 (de) * 1987-08-20 1998-05-15 Childrens Medical Center Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
DE68926916T2 (de) * 1988-04-14 1997-01-30 Incyte Pharma Inc 14-Beta-gal Sauger-Lectin

Also Published As

Publication number Publication date
IL99940A0 (en) 1992-08-18
EP0555286B1 (de) 2001-08-08
GB9123036D0 (en) 1991-12-18
DE69132682D1 (de) 2001-09-13
GB2249312A (en) 1992-05-06
GB9023907D0 (en) 1990-12-12
US6127169A (en) 2000-10-03
CA2095335A1 (en) 1992-05-03
DE69132682T2 (de) 2002-07-04
JPH06502302A (ja) 1994-03-17
WO1992007938A1 (en) 1992-05-14
EP0555286A1 (de) 1993-08-18
IE913816A1 (en) 1992-05-22
AU650066B2 (en) 1994-06-09
GB2249312B (en) 1994-11-16
AU8756591A (en) 1992-05-26
CA2095335C (en) 2002-10-22
JP3497504B2 (ja) 2004-02-16

Similar Documents

Publication Publication Date Title
DE69434808D1 (de) Adenoviren mit veränderten faserproteinen
HUP0104717A2 (hu) Készítmények és eljárások petefészekrák terápiájára és diagnózisára
DK0751781T3 (da) Anvendelse af monoklonale antistoffer eller oplöselige oligomere ligander til fremstillingen af et medikament til forebyggelse eller behandling af neoplastiske sygdomme
ATE189527T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
DE69131699D1 (de) Verändertes menschliches iL-6
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ID22042A (id) Benzonaftiridin sebagai pengobatan cabang tenggorokan
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
DE69132682D1 (de) Zellwachstumsinhibitoren
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
DK0837935T3 (da) Den 3'-ikke-translaterede region af det humane prohibitin-gen
DK0687184T3 (da) Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme
DK0841939T3 (da) Terapeutiske midler og autoimmune sygdomme
BR9609620A (pt) 2-aminocarbonil-1,2-bis(metilsulfonil)-1-(substituìda s)hidrazinas antitumorais.
DE69013011D1 (de) Bcrf1-proteine als inhibitoren von interferon-g(g).
FI942442A0 (fi) Proteiinien tuotto 7B2-proteiinia käyttäen
DK0783307T3 (da) Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen
NO931413L (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
DE69732246D1 (de) Gewebespezifische expression des retinoblastoma-proteins
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
TR199500984A2 (tr) Selegilin'in epileptik hastaliklarin tedavisinde kullanimi.
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff
UA23310A (uk) Спосіб лікуваhhя ішемічhої хвороби серця з супровідhою патологією гєпатобіліарhої системи

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties